title: Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
authors.forename: Sergio
authors.initials: S
authors.lastname: Giralt
authors.forename: David H
authors.initials: DH
authors.lastname: Vesole
authors.forename: George
authors.initials: G
authors.lastname: Somlo
authors.forename: Amrita
authors.initials: A
authors.lastname: Krishnan
authors.forename: Edward
authors.initials: E
authors.lastname: Stadtmauer
authors.forename: Philip
authors.initials: P
authors.lastname: Mccarthy
authors.forename: Marcelo C
authors.initials: MC
authors.lastname: Pasquini
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D018572:Disease-Free Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D000077269:Lenalidomide; D015201:Meta-Analysis as Topic; D009101:Multiple Myeloma / Q000401:mortality* / Q000601:surgery*; D011719:Pyrazines / Q000008:administration & dosage; D012107:Research Design; D016879:Salvage Therapy / Q000379:methods; D016019:Survival Analysis; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D014182:Transplantation, Autologous
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D000077269:Lenalidomide